20 results found.

Venous Thromboembolism Clinical Trial using dabigatran etexilate; standard of care

Boehringer Ingelheim - Recruiting N/A to 17 years.
- Open-label, Randomized, Parallel-group, Active-controlled, Multi-centre Non-inferiority Study of Dabigatran Etexilate Versus Standard of Care for Venous Thromboembolism Treatment in Children From Birth to Less Than 18 Years of Age.
dabigatran etexilate; standard of care

Venous Thromboembolism Clinical Trial using dabigatran etexilate

Boehringer Ingelheim - Recruiting 1 year to 11 years.
- Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Successive Groups of Children Aged 2 Years to Less Than 12 Years Followed by 1 Year to Less Than 2 Years.
dabigatran etexilate

Venous Thromboembolism Clinical Trial using dabigatran etexilate

Boehringer Ingelheim - Recruiting 1 year to 2 years.
- Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89.
dabigatran etexilate

Venous Thromboembolism Clinical Trial

Indiana University - Recruiting N/A or older.
- Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant.

Recent Stroke, Pulmonary Embolism, or Patent Foramen Ovale Clinical Trial

University Hospital, Brest - Recruiting 18 years or older.
- Is There a Link Between Venous Thromboembolism and Stroke in Patient With Patent Foramen Ovale ? Research for Stroke in Hospitalized Patients With Pulmonary Embolism..

Obesity, Obesity, Morbid, Pregnancy, Complications; Cesarean Sect Clinical Trial using Enoxaparin

MemorialCare Health System - Recruiting 18 years or older.
- Comparing Anti-XA Levels in Post-Cesarean Patients With BMI >35 Undergoing Enoxaparin Thromboprophylaxis With Weight Based Dosing Twice Daily Versus Fixed Dose 40 Milligrams Daily.
Enoxaparin

HIV, Atrial Fibrillation, or Venous Thromboembolism Clinical Trial using Ritonavir; Cobicistat

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 70 years.
- The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Pharmacodynamics in Healthy Volunteers.
Ritonavir; Cobicistat

Deep Vein Thrombosis, or Venous Thrombosis Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939); Standard of care

Bayer - Recruiting 18 years or older.
- Xareltor for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE).
Rivaroxaban (Xarelto, BAY59-7939); Standard of care

Deep Vein Thrombosis, Venous Thrombosis, Postphlebitic Syndrome, Clinical Trial using Recombinant tissue plasminogen activator (rt-PA)

Washington University School of Medicine - Recruiting 16 years to 75 years.
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial.
Recombinant tissue plasminogen activator (rt-PA)

Venous Thromboembolism (VTE) Clinical Trial using Betrixaban; Enoxaparin

Portola Pharmaceuticals - Recruiting 40 years or older.
- (Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients.
Betrixaban; Enoxaparin

Venous Thrombosis, or Pediatrics Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939)

Bayer - Recruiting 6 Months to 18 years.
- Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism.
Rivaroxaban (Xarelto, BAY59-7939)

Venous Thromboembolism, or Cancer Clinical Trial using Apixaban; Placebo drug

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients: A Randomized Placebo-Controlled, Double-Blind Clinical Trial.
Apixaban; Placebo drug

Venous Thromboembolism Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939); Pharmacologic agents (e.g. LMWH/VKA/Fondaparinux/Aspirin and etc.)

Bayer - Recruiting 18 years or older.
- Xareltor Regulatory Post-Marketing Surveillance.
Rivaroxaban (Xarelto, BAY59-7939); Pharmacologic agents (e.g. LMWH/VKA/Fondaparinux/Aspirin and etc.)

Malignant Female Reproductive System Neoplasm Clinical Trial using Enoxaparin, Heparin

National Guard Health Affairs - Recruiting 18 years or older.
- A Randomized, Controlled, Open Label Study of the Efficacy and Safety of the Low Molecular Weight Heparin (LMWH), LovenoxTM (Enoxaparin) Versus HeparinTM (Unfractionated Heparin) for Prevention of Venous Thromboembolism (VTE) in Gynecologic Oncology Patients.
Enoxaparin, Heparin

Deep Vein Thrombosis Clinical Trial

Indiana University - Recruiting 1 Month to 12 years.
- Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures.

Venous Thromboembolism, or Postpartum Clinical Trial using Dalteparin Sodium

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- Postpartum Prophylaxis for PE Randomized Control Trial Pilot: A Pilot Study Assessing Feasibility of a Randomized, Open-label Trial of Low-Molecular-Weight-Heparin for Postpartum Prophylaxis in Women at Risk of Developing Venous Thromboembolism.
Dalteparin Sodium

Venous Thromboembolism, or Pulmonary Embolism Clinical Trial using dalteparin injection

University of Rochester - Recruiting 18 years or older.
- A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients.
dalteparin injection

Medical Patient, or Thrombocytopenia Clinical Trial using Fondaparinux

G. d'Annunzio University - Recruiting 18 years or older.
- Thromboprophylaxis With Fondaparinux of Deep Vein Thrombosis and Pulmonary Embolism in the Acutely-ill Medical Inpatients With Thrombocytopenia.
Fondaparinux

Intracerebral Hemorrhage Clinical Trial using enoxaparin; enoxaparin placebo

University of Oulu - Recruiting 18 years or older.
- A Double-blind Randomized Trial to Compare the Efficacy of Intermittent Pneumatic Compression (IPC) With and Without Early Anticoagulant Treatment for Prevention of Venous Thromboembolism (VTE) in Patients With Acute Primary Intracerebral Hemorrhage (ICH).
enoxaparin; enoxaparin placebo

Deep Venous Thrombosis Clinical Trial using Phenprocoumon; Warfarin-Natrium

University Hospital, Bonn - Recruiting 18 years to 85 years.
- Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial.
Phenprocoumon; Warfarin-Natrium